Xenoestrogens Challenge 17β-estradiol Protective Effects in Colon Cancer

World Journal of Gastrointestinal Oncology

Volumn 6, Issue 3, 2014, Pages 67-73

  Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

17 Estradiol; Bisphenol A; Colorectal cancer; Estrogen receptors; Flavonoids; Xenoestrogens

Indexed keywords

EID: 84903192294     PISSN: None     EISSN: 19485204     Source Type: Journal    
DOI: 10.4251/wjgo.v6.i3.67     Document Type: Article

References (69)

1. 1 Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 2006; 27: 299-402 [PMID: 16914190 DOI: 10.1016/j.mam.2006.07.001].
2. 2 Jick SS, Hagberg KW, Kaye JA, Jick H. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Obstet Gynecol 2009; 113: 74-80 [PMID: 19104362].
3. 3 Suzuki F, Akahira J, Miura I, Suzuki T, Ito K, Hayashi S, Sasano H, Yaegashi N. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5’-untranslated region in human epithelial ovarian carcinoma. Cancer Sci 2008; 99: 2365-2372 [PMID: 19032364 DOI: 10.1111/j.1349-7006.2008.00988.x].
4. 4 Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008; 9: 385-391 [PMID: 18374292 DOI:10.1016/S1470-2045(08)70100-1].
5. 5 Acconcia F, Marino M. The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane. Front Physiol 2011; 2: 30 [PMID: 21747767 DOI:10.3389/fphys.2011.00030].
6. 6 Thomas C, Gustafsson JÅ. The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 2011; 11: 597-608 [PMID: 21779010 DOI: 10.1038/nrc3093].
7. 7 Marino M, Pellegrini M, La Rosa P, Acconcia F. Susceptibility of estrogen receptor rapid responses to xenoestrogens:Physiological outcomes. Steroids 2012; 77: 910-917 [PMID:22410438 DOI: 10.1016/j.steroids.2012.02.019].
8. 8 Marino M, Acconcia F, Bresciani F, Weisz A, Trentalance A. Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell 2002; 13:3720-3729 [PMID: 12388769 DOI: 10.1091/mbc.E02-03-0153].
9. 9 Marino M, Acconcia F, Trentalance A. Biphasic estradiolinduced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell 2003; 14: 2583-2591 [PMID: 12808053 DOI: 10.1091/mbc.E02-09-0621].
10. 10 Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S,Trentalance A, Muramatsu M, Marino M. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 2005; 203:193-201 [PMID: 15389627 DOI: 10.1002/jcp.20219].
11. 11 Warner M, Gustafsson JA. The role of estrogen receptor beta (ERbeta) in malignant diseases––a new potential target for antiproliferative drugs in prevention and treatment of cancer. Biochem Biophys Res Commun 2010; 396: 63-66 [PMID:20494112 DOI: 10.1016/j.bbrc.2010.02.144].
12. 12 Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M, Gustafsson JA. Update on estrogen signaling. FEBS Lett 2003; 546: 17-24 [PMID: 12829231 DOI: 10.1016/S0014-5793(03)00436-8].
13. 13 Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004; 11: 537-551[PMID: 15369453 DOI: 10.1677/erc.1.00800].
14. 14 Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004; 64: 423-428 [PMID:14729654 DOI: 10.1158/0008-5472.CAN-03-2446].
15. 15 Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor beta inhibits 17beta-estradiolstimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004; 101: 1566-1571 [PMID: 14745018 DOI: 10.1073/pnas.0308319100].
16. 16 Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer 2007; 14: 153-167 [PMID:17395984 DOI: 10.1677/ERC-06-0020].
17. 17 Caiazza F, Galluzzo P, Lorenzetti S, Marino M. 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun 2007; 359:102-107 [PMID: 17524358 DOI: 10.1016/j.bbrc.2007.05.059].
18. 18 Bolli A, Marino M. Current and future development of estrogen receptor ligands: applications in estrogen-related cancers. Recent Pat Endocr Metab Immune Drug Discov 2011; 5:210-229 [PMID: 21913884 DOI: 10.2174/187221411797265881].
19. 19 Clapp RW, Jacobs MM, Loechler EL. Environmental and occupational causes of cancer: new evidence 2005-2007. Rev Environ Health 2008; 23: 1-37 [PMID: 18557596 DOI: 10.1515/REVEH.2008.23.1.1].
20. 20 Hogan AM, Collins D, Baird AW, Winter DC. Estrogen and gastrointestinal malignancy. Mol Cell Endocrinol 2009; 307:19-24 [PMID: 19524122 DOI: 10.1016/j.mce.2009.03.016].
21. 21 Böttner M, Thelen P, Jarry H. Estrogen receptor beta: tissue distribution and the still largely enigmatic physiological function. J Steroid Biochem Mol Biol 2014; 139: 245-251 [PMID:23523517 DOI: 10.1016/j.jsbmb.2013.03.003].
22. 22 Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med 1993; 118:366-375 [PMID: 8257464 DOI: 10.7326/0003-4819-118-5-199303010-00008].
23. 23 Kawano N, Koji T, Hishikawa Y, Murase K, Murata I, Kohno S. Identification and localization of estrogen receptor alphaand beta-positive cells in adult male and female mouse intestine at various estrogen levels. Histochem Cell Biol 2004; 121:399-405 [PMID: 15138841 DOI: 10.1007/s00418-004-0644-6].
24. 24 Beckett EA, McCloskey C, O’Kane N, Sanders KM, Koh SD. Effects of female steroid hormones on A-type K+ currents in murine colon. J Physiol 2006; 573: 453-468 [PMID: 16581861 DOI: 10.1113/jphysiol.2006.107375].
25. 25 Choijookhuu N, Sato Y, Nishino T, Endo D, Hishikawa Y, Koji T. Estrogen-dependent regulation of sodium/hydrogen exchanger-3 (NHE3) expression via estrogen receptor β in proximal colon of pregnant mice. Histochem Cell Biol 2012; 137:575-587 [PMID: 22358497 DOI: 10.1007/s00418-012-0935-2].
26. 26 Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263 [PMID: 9751507].
27. 27 Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001; 61: 632-640 [PMID: 11212261].
28. 28 Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation. Eur J Cancer 2003; 39: 1251-1258 [PMID: 12763213 DOI:10.1016/S0959-8049(03)00239-9].
29. 29 Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 2005; 207: 53-60 [PMID:15954165 DOI: 10.1002/path.1807].
30. 30 Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW.Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000; 60: 245-248 [PMID: 10667568].
31. 31 Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7:536-540 [PMID: 7951326 DOI: 10.1038/ng0894-536].
32. 32 Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K,Schwend T, Omoto Y, Warner M, Gustafsson JA. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci USA 2006; 103: 2959-2964 [PMID: 16477031 DOI: 10.1073/pnas.0511271103].
33. 33 Wada-Hiraike O, Warner M, Gustafsson JA. New developments in oestrogen signalling in colonic epithelium. Biochem Soc Trans 2006; 34: 1114-1116 [PMID: 17073763 DOI: 10.1042/BST0341114].
34. 34 Potter JD. Colorectal cancer: molecules and populations.J Natl Cancer Inst 1999; 91: 916-932 [PMID: 10359544 DOI:10.1093/jnci/91.11.916].
35. 35 Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN,Anderson K, Schaffer D, Samowitz WS. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001; 61: 126-130[PMID: 11196149].
36. 36 GLOBOCAN Colorectal Cancer Data (2008). Available from:URL: http //globocan.iarc.fr/factsheets/cancers/colorectal.asp.
37. 37 Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL.Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532 [PMID: 2841597 DOI: 10.1056/NEJM198809013190901].
38. 38 DeCosse JJ, Ngoi SS, Jacobson JS, Cennerazzo WJ. Gender and colorectal cancer. Eur J Cancer Prev 1993; 2: 105-115[PMID: 8461861 DOI: 10.1097/00008469-199303000-00003].
39. 39 McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980; 65: 1201-1207 [PMID:7001123].
40. 40 Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV. Critical role of oxidative stress in estrogen-induced carcinogenesis.Proc Natl Acad Sci USA 2003; 100: 3913-3918 [PMID: 12655060 DOI: 10.1073/pnas.0437929100].
41. 41 Guo JY, Li X, Browning JD, Rottinghaus GE, Lubahn DB,Constantinou A, Bennink M, MacDonald RS. Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 2004; 134: 179-182 [PMID: 14704314].
42. 42 Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM. Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 2007; 67: 2366-2372 [PMID: 17332369 DOI: 10.1158/0008-5472.CAN-06-3026].
43. 43 Waliszewski P, Blaszczyk M, Wolinska-Witort E, Drews M, Snochowski M, Hurst RE. Molecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas. J Surg Oncol 1997; 64: 3-11 [PMID: 9040793 DOI:10.1002/(SICI)1096-9098(199701)64].
44. 44 Weyant MJ, Carothers AM, Mahmoud NN, Bradlow HL,Remotti H, Bilinski RT, Bertagnolli MM. Reciprocal expression of ERalpha and ERbeta is associated with estrogenmediated modulation of intestinal tumorigenesis. Cancer Res 2001; 61: 2547-2551 [PMID: 11289129].
45. 45 Fiorelli G, Picariello L, Martineti V, Tonelli F, Brandi ML.Functional estrogen receptor beta in colon cancer cells.Biochem Biophys Res Commun 1999; 261: 521-527 [PMID:10425218 DOI: 10.1006/bbrc.1999.1062].
46. 46 Qiu Y, Waters CE, Lewis AE, Langman MJ, Eggo MC.Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002; 174: 369-377 [PMID:12208656 DOI: 10.1677/joe.0.1740369].
47. 47 Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271: C1424-C1437 [PMID: 8944624].
48. 48 Marino M, Galluzzo P, Leone S, Acconcia F, Ascenzi P. Nitric oxide impairs the 17beta-estradiol-induced apoptosis in human colon adenocarcinoma cells. Endocr Relat Cancer 2006;13: 559-569 [PMID: 16728582 DOI: 10.1677/erc.1.01106].
49. 49 Nathan C. The moving frontier in nitric oxide-dependent signaling. Sci STKE 2004; 2004: pe52 [PMID: 15523044].
50. 50 Wilkins HR, Doucet K, Duke V, Morra A, Johnson N. Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2. Tumour Biol 2010; 31: 16-22 [PMID: 20237898 DOI:10.1007/s13277-009-0003-2].
51. 51 Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009; 30: 293-342 [PMID: 19502515 DOI: 10.1210/er.2009-0002].
52. 52 Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE,Soto AM, Woodruff TJ, Vom Saal FS. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 2012; 153:4097-4110 [PMID: 22733974 DOI: 10.1210/en.2012-1422].
53. 53 Bulzomi P, Marino M. Environmental endocrine disruptors:does a sex-related susceptibility exist? Front Biosci (Landmark Ed) 2011; 16: 2478-2498 [PMID: 21622190 DOI: 10.2741/3867].
54. 54 Sokolosky ML, Wargovich MJ. Homeostatic imbalance and colon cancer: the dynamic epigenetic interplay of inflammation, environmental toxins, and chemopreventive plant compounds. Front Oncol 2012; 2: 57 [PMID: 22675672 DOI:10.3389/fonc.2012.00057].
55. 55 Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007; 24: 178-198 [PMID: 17628395 DOI: 10.1016/j.reprotox.2007.05.010].
56. 56 Singleton DW, Feng Y, Yang J, Puga A, Lee AV, Khan SA. Gene expression profiling reveals novel regulation by bisphenol-A in estrogen receptor-alpha-positive human cells. Environ Res 2006; 100: 86-92 [PMID: 16029874].
57. 57 Bolli A, Bulzomi P, Galluzzo P, Acconcia F, Marino M.Bisphenol A impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth. IUBMB Life 2010; 62:684-687 [PMID: 20836126 DOI: 10.1002/iub.370].
58. 58 Messina M, Hilakivi-Clarke L. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer 2009; 61: 792-798 [PMID: 20155618 DOI: 10.1080/01635580903285015].
59. 59 Galluzzo P, Marino M. Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.Genes Nutr 2006; 1: 161-176 [PMID: 18850212 DOI: 10.1007/BF02829966].
60. 60 Kyle JA, Sharp L, Little J, Duthie GG, McNeill G. Dietary flavonoid intake and colorectal cancer: a case-control study. Br J Nutr 2010; 103: 429-436 [PMID: 19732470 DOI: 10.1017/S0007114509991784].
61. 61 Ramos S. Cancer chemoprevention and chemotherapy:dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008; 52: 507-526 [PMID: 18435439 DOI: 10.1002/mnfr.200700326].
62. 62 Galluzzo P, Ascenzi P, Bulzomi P, Marino M. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology 2008; 149: 2567-2575 [PMID: 18239068 DOI: 10.1210/en.2007-1173].
63. 63 Totta P, Acconcia F, Leone S, Cardillo I, Marino M. Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling.IUBMB Life 2004; 56: 491-499 [PMID: 15545229].
64. 64 Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals. J Cell Physiol 2012; 227:1891-1898 [PMID: 21732360 DOI: 10.1002/jcp.22917].
65. 65 Virgili F, Marino M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med 2008; 45:1205-1216 [PMID: 18762244 DOI: 10.1016/j.freeradbiomed.2008.08.001].
66. 66 Bulzomi P, Bolli A, Galluzzo P, Acconcia F, Ascenzi P, Marino M. The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 2012; 64: 690-696 [PMID: 22692793 DOI: 10.1002/iub.1049].
67. 67 Bergman A, Heindel JJ, Kasten T, Kidd KA, Jobling S, Neira M, Zoeller RT, Becher G, Bjerregaard P, Bornman R, Brandt I, Kortenkamp A, Muir D, Drisse MN, Ochieng R, Skakkebaek NE, Byléhn AS, Iguchi T, Toppari J, Woodruff TJ. The impact of endocrine disruption: a consensus statement on the state of the science. Environ Health Perspect 2013; 121: A104-A106 [PMID: 23548368 DOI: 10.1289/ehp.1205448].
68. 68 Newbold RR. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 2000; 9: 206-217 [PMID: 20688618].
69. 69 Selevan SG, Kimmel CA, Mendola P. Identifying critical windows of exposure for children’s health. Environ Health Perspect 2000; 108 Suppl 3: 451-455 [PMID: 10852844].